Hypothyroidism Clinical Trial
Official title:
The Effects of an Anti-inflammatory Diet With or Without Curcumin Supplementation on Anthropometric Measurements, Concentrations of Thyroid Hormones, Anti-TPO, and Systemic Inflammation in Plasma and NFK-B in Peripheral Blood Mononuclear Cells in Patients With Hashimato
Verified date | July 2023 |
Source | National Nutrition and Food Technology Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this clinical trial is to investigate The effects of an anti-inflammatory diet with or without curcumin supplementation on anthropometric measurements, concentrations of thyroid hormones, anti-TPO, and systemic inflammation in plasma and NFK-B in peripheral blood mononuclear cells in patients with Hashimoto. The main questions it aims to answer are: 1. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in anthropometric measurements (weight, body mass index, BMI, waist circumference, waist-to-hip ratio) in patients with Hashimoto's disease? 2. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in the serum concentration of thyroid hormones (T3, T4, TSH) in patients with Hashimoto's disease? 3. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the change of Anti-TPO concentration in patients with Hashimoto's disease? 4. Does prescribing an anti-inflammatory diet with or without curcumin supplementation significantly affect the changes in systemic inflammation indicators (hs-CRP, IL-6) in plasma and NF-κB in peripheral blood mononuclear cells in patients with Hashimoto's disease?
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | June 30, 2025 |
Est. primary completion date | April 19, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 70 Years |
Eligibility | Inclusion Criteria: Having Hashimoto's thyroiditis Willingness to cooperate Body mass index between 35 and 18.5 TSH less than ten and without clinical symptoms Not taking levothyroxine tablets Exclusion Criteria: Pregnancy and breastfeeding kidney Diseases Follow non-routine weight loss diets for three months before the start of the study × Taking slimming and fat-burning drugs, fiber powder Mineral, vegetable, and fiber vitamin supplements |
Country | Name | City | State |
---|---|---|---|
Iran, Islamic Republic of | Golbon Sohrab | Tehran | National Nutrition And Food Technology Research Institute |
Lead Sponsor | Collaborator |
---|---|
National Nutrition and Food Technology Institute |
Iran, Islamic Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | IL6 | Interleukin 6 | 3 month | |
Primary | hs-Crp | high-sensitivity C-reactive protein | 3 month | |
Primary | NF-KB | Nuclear factor kappa-light-chain-enhancer of activated B cells | 3 month | |
Primary | Anti-tpo | antithyroperoxidase | 3 month | |
Primary | T4 | Thyroxine | 3 month | |
Primary | T3 | Triiodothyronine | 3 month | |
Primary | TSH | Thyroid-stimulating hormone | 3 month | |
Primary | waist circumference | waist circumference in Centimeter | 3 month | |
Primary | hip circumference | hip circumference in Centimeter | 3 month | |
Primary | waist to hip ratio | an Anthropometric index | 3 month | |
Primary | BMI | Body Mass Index - Anthropometric index | 3 month | |
Primary | Total Cholestrol | serum lipid profile | 3 month | |
Primary | TG | Triglyceride - serum lipid profile | 3 month | |
Primary | Hb | hemoglobin - Blood test | 3 month | |
Primary | hematocrit | Blood test | 3 month | |
Primary | LDL | low-density lipoprotein | 3 month | |
Primary | HDL | high-density lipoprotein | 3 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05334771 -
Early Detection of Endolymphatic Hydrops in Hypothyroid Patients
|
||
Withdrawn |
NCT01707056 -
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
|
N/A | |
Completed |
NCT00094237 -
Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke
|
N/A | |
Recruiting |
NCT06015620 -
Comorbidities Resolution After MGB Surgery and Change in Body Composition
|
||
Completed |
NCT03612908 -
TSHβX1 and D2 THR92ALA in Pregnancy
|
||
Completed |
NCT04782856 -
Energy Metabolism in Thyroidectomized Patients
|
Phase 2 | |
Completed |
NCT01921452 -
Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit
|
Phase 4 | |
Completed |
NCT01197183 -
Observational Study With Prospective and/or Retrospective Follow-up, Without Modifying Patient Treatment and Follow-up Practices for the Initial Treatment of Hypothyroidism in France
|
N/A | |
Recruiting |
NCT05247476 -
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
|
Phase 4 | |
Recruiting |
NCT03754621 -
Upper Limit for TSH of First and Second Trimester Pregnancy in Turkey
|
||
Completed |
NCT02959827 -
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
|
||
Completed |
NCT04124705 -
A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants
|
Phase 2 | |
Withdrawn |
NCT02577367 -
Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding
|
Phase 4 | |
Completed |
NCT04098991 -
Improving White Matter Integrity With Thyroid Hormone
|
||
Not yet recruiting |
NCT03257566 -
Hypothyroidism in Patients With Type 1 Diabetes
|
N/A | |
Terminated |
NCT02567877 -
Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
|
||
Completed |
NCT02280330 -
Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months
|
Phase 4 | |
Completed |
NCT00403390 -
Generic vs. Name-Brand Levothyroxine
|
N/A | |
Not yet recruiting |
NCT06096454 -
Effect of Life Style Modification and Metformin on Hypothyroidism With Insulin Resistance
|
Phase 4 | |
Completed |
NCT04528225 -
A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer
|